136 related articles for article (PubMed ID: 29618424)
1. Formulation of nanoparticles ribosome inactivating proteins from Mirabilis jalapa L. (RIP MJ) conjugated AntiEpCAM antibody using low chain chitosan-pectin and cytotoxic activity against breast cancer cell line.
Pertiwi D; Martien R; Sismindari -; Ismail H
Pak J Pharm Sci; 2018 Mar; 31(2):379-384. PubMed ID: 29618424
[TBL] [Abstract][Full Text] [Related]
2. Formulation and Cytotoxicity of Ribosome-Inactivating Protein Mirabilis Jalapa L. Nanoparticles Using Alginate-Low Viscosity Chitosan Conjugated with Anti-Epcam Antibodies in the T47D Breast Cancer Cell Line.
Wicaksono PA; Name S; Martien R; Ismail H
Asian Pac J Cancer Prev; 2016; 17(4):2277-84. PubMed ID: 27221930
[TBL] [Abstract][Full Text] [Related]
3. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
4. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
5. Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cells.
Chittasupho C; Jaturanpinyo M; Mangmool S
Drug Deliv; 2013; 20(1):1-9. PubMed ID: 23216416
[TBL] [Abstract][Full Text] [Related]
6. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
7. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
8. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
9. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.
Mehrotra A; Nagarwal RC; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411
[TBL] [Abstract][Full Text] [Related]
10. Novel polymer coupled lipid nanoparticle of paclitaxel with synergistic enhanced efficacy against cancer.
Singodia D; Talegaonkar S; Khar RK; Mishra PR
J Biomed Nanotechnol; 2011 Feb; 7(1):125-6. PubMed ID: 21485835
[TBL] [Abstract][Full Text] [Related]
11. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.
Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
Pharm Res; 2016 Sep; 33(9):2218-2228. PubMed ID: 27251414
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
Sabra R; Billa N; Roberts CJ
Int J Pharm; 2019 Dec; 572():118775. PubMed ID: 31678385
[TBL] [Abstract][Full Text] [Related]
15. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
16. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of Crotalus molossus molossus snake venom-loaded in chitosan nanoparticles against T-47D breast carcinoma cells.
Jimenez-Canale J; Fernandez-Quiroz D; Teran-Saavedra NG; Diaz-Galvez KR; Gallegos-Tabanico A; Burgara-Estrella AJ; Sarabia-Sainz HM; Guzman-Partida AM; Robles-Burgueño MDR; Vazquez-Moreno L; Sarabia-Sainz JA
Acta Biochim Pol; 2022 Feb; 69(1):233-243. PubMed ID: 35148045
[TBL] [Abstract][Full Text] [Related]
18. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
19. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
20. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
